Suppression of phosphoenolpyruvate carboxykinase gene expression by secoisolariciresinol diglucoside (SDG), a new antidiabetic agent

International Journal of Angiology

Volumn 11, Issue 2, 2002, Pages 107-109

  Prasad, Kailash ^a,b  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; INSULIN; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); SECOISOLARICIRESINOL; SECOISOLARICIRESINOL DIGLUCOSIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG INHIBITION; DRUG MECHANISM; GENE EXPRESSION; GENE REPRESSION; HYPOGLYCEMIA; LIVER CELL CULTURE; MALE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; RAT;

EID: 0036389398     PISSN: 10611711     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00547-001-0071     Document Type: Article

References (24)

1. Olefsky JM, Ciaraldi TP, Kolterman OG (1985) Mechanism of insulin resistance in non-insulin-dependent (type-2) diabetes. Am J Med 79 (suppl 3B):12-22.
2. Olefsky JM (1985) Pathogenesis of insulin resistance and hyperglycemia in non-insulin-dependent diabetes mellitus. Am J Med 79 (suppl 3B):1-7.
3. DeFronzo RA (1988) The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 37:667-687.
4. Consoli A, Nurjhan N, Capani F, Gerich J (1989) Predominant role of gluconeogenesis in increased hepatic glucose production in NIDDM. Diabetes 38:550-557.
5. 13C nuclear magnetic resonance study. J Clin Invest 90:1323-1327.
6. Fujiwara T, Yoshioka S, Yoshioka T, Ushiyama I, Horikoshi H (1988) Characterization of a new oral antidiabetic agent CS-O45. Studies in KK and ob/ob mice and Zucker fatty rats. Diabetes 37:1549-1558.
7. Rognstad R (1979) Rate-limiting steps in metabolic pathways. J Biol Chem 254:1875-1878.
8. Nandan SD, Beale EG (1992) Regulation of phosphoenolpyruvate carboxykinase mRNA in mouse liver, kidney and fat tissues by fasting, diabetes and insulin. Lab Anim Sci 42:473-477.
9. Veneziale CM, Donofrio JC, Nishimura H (1983) The concentration of P-enolpyruvate carboxykinase protein in murine tissues in diabetes of chemical and genetic origin. J Biol Chem 258:14257-14262.
10. Chang AY, Schneider D (1970) Abnormalities in hepatic enzyme activities during development of diabetes in db mice. Diabetologia 6:274-278.
11. Shargo E, Lardy HA, Nordlie RC, Fraser DO (1963) Metabolic and hormonal control of phosphoenolpyruvate carboxykinase and malic enzyme in rat liver. J Biol Chem 238:3188-3192.
12. Loose DS, Wynshaw-Boris A, Meisner HM, Dod Y, Hanson RW (1985) Hormonal regulation of phosphoenolpyruvate carboxykinase gene expression. In: Molecular basis of insulin action. Czech MP (ed.) Plenum:New York, pp 347-368.
13. Saltiel AR, Olefsky JM (1996) Thiazolidinediones in the treatment of insulin resistance and type II diabetes. Diabetes 45:1661-1669.
14. Davies GF, Khandelwal RL, Roesler WJ (1999) Troglitazone inhibits expression of phosphoenolpyruvate carboxykinase gene by an insulin-independent mechanism. Biochem Biophys Acta 1451:122-131.
15. Davies GF, Khandelwal RL, Wu L, Juurlink BHJ, Roesler WJ (2001) Inhibition of phosphoenolpyruvate carboxykinase (PEP-CK) gene expression by troglitazone: a peroxisome proliferator-activated receptor-γ (PPAR γ)-independent, antioxidant-related mechanism. Biochem Pharmacol 62:1071-1079.
16. Prasad K (1997) Hydroxyl radical-scavenging property of secoisolariciresinol diglucoside (SDG) isolated from flaxseed. Mol Cell Biochem 168:117-123.
17. Prasad K (2000) Antioxidant activity of secoisolariciresinol diglucoside-derived metabolites, secoisolariciresinol, enterodiol, and enterolactone. Intl J Angiol 9:220-225.
18. Prasad K, Mantha SV, Muir AD, Westcott ND (2000) Protective effect of secoisolariciresinol diglucoside against streptozotocin-induced diabetes and its mechanism. Mol Cell Biochem 206:141-150.
19. Prasad K (2000) Oxidative stress as a mechanism of diabetes in diabetic prone BB rats: effects of secoisolariciresinol diglucoside (SDG). Mol Cell Biochem 209:89-96.
20. Prasad K (2001) Secoisolariciresinol diglucoside from flaxseed delays the development of type-2 diabetes in Zucker rat. J Lab Clin Med 138:32-39.
21. Cascales C, Mangiapane EH, Brindley DN (1984) Oleic acid promotes the activation and translocation of phosphatidate phosphohydrolase from the cytosol to particulate fractions of isolated rat hepatocytes. Biochem J 219:911-916.
22. Hanson RW, Patel YM (1994) Phosphoenolpyruvate carboxykinase (GTP): the gene and the enzyme. Adv Enzymol Relat Areas Mol Biol 69:203-281.
23. Inoue I, Katayama S, Takahashi K, Negishi K, Miyazaki T, Sonoda M, Komoda T (1997) Troglitazone has a scavenging effect on reactive oxygen species. Biochem Biophys Res Commun 235:113-116.
24. Burton GW, Traber MG (1990) Vitamin E:antioxidant activity, biokinetics, and bioavailability. Ann Rev Nutr 10:357-382.